Sio Gene Therapies Inc. (SIOX) Covered Calls

You can sell covered calls on Sio Gene Therapies Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SIOX (prices last updated Fri 4:16 PM ET):

Sio Gene Therapies Inc. (SIOX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.58 -0.06 1.55 1.65 463K - 0.1
Covered Calls For Sio Gene Therapies Inc. (SIOX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 17 2 0.00 1.65 0.0% 0.0%
Jan 21 2 0.10 1.55 6.5% 41.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Sio Gene Therapies, Inc., a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-GM1 program for the treatment of GM1 gangliosidosis; and AXO-AAV-GM2 program for the treatment of GM2 gangliosidosis. It has a license agreement with Oxford BioMedica (UK) Ltd. and The University of Massachusetts Medical School. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was founded in 2014 and is based in New York, New York.